Evidence map›Paper›PMID 26474830›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Antifungal activity improved by coproduction of cyclodextrins and anabaenolysins in Cyanobacteria.

Tania K Shishido, Jouni Jokela, Clara-Theresia Kolehmainen, David P Fewer, Matti Wahlsten, Hao Wang, Leo Rouhiainen, Ermanno Rizzi, Gianluca De Bellis, Perttu Permi and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Tania K ShishidoDepartment of Food and Environmental Sciences, University of Helsinki, FI-00014, Helsinki, Finland;
Jouni JokelaDepartment of Food and Environmental Sciences, University of Helsinki, FI-00014, Helsinki, Finland;
Clara-Theresia KolehmainenDepartment of Food and Environmental Sciences, University of Helsinki, FI-00014, Helsinki, Finland;
David P FewerDepartment of Food and Environmental Sciences, University of Helsinki, FI-00014, Helsinki, Finland;
Matti WahlstenDepartment of Food and Environmental Sciences, University of Helsinki, FI-00014, Helsinki, Finland;
Hao WangDepartment of Food and Environmental Sciences, University of Helsinki, FI-00014, Helsinki, Finland;
Leo RouhiainenDepartment of Food and Environmental Sciences, University of Helsinki, FI-00014, Helsinki, Finland;
Ermanno RizziInstitute of Biomedical Technologies, National Research Council, 20090, Segrate, Milan, Italy;
Gianluca De BellisInstitute of Biomedical Technologies, National Research Council, 20090, Segrate, Milan, Italy;
Perttu PermiProgram in Structural Biology and Biophysics, Institute of Biotechnology/Nuclear Magnetic Resonance Laboratory, University of Helsinki, FI-00014, Helsinki, Finland; Department of Biological and Environmental Science, Nanoscience Center, University of Jyväskylä, FI-40014, Jyväskylä, Finland; Department of Chemistry, Nanoscience Center, University of Jyväskylä, FI-40014, Jyväskylä, Finland.
Kaarina SivonenDepartment of Food and Environmental Sciences, University of Helsinki, FI-00014, Helsinki, Finland; kaarina.sivonen@helsinki.fi.
University of Helsinki · FIInstitute of Biomedical Technologies · ITNational Research Council · ITUniversity of Jyväskylä · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclodextrins are cyclic oligosaccharides widely used in the pharmaceutical industry to improve drug delivery and to increase the solubility of hydrophobic compounds. Anabaenolysins are lipopeptides produced by cyanobacteria with potent lytic activity in cholesterol-containing membranes. Here, we identified the 23- to 24-kb gene clusters responsible for the production of the lipopeptide anabaenolysin. The hybrid nonribosomal peptide synthetase and polyketide synthase biosynthetic gene cluster is encoded in the genomes of three anabaenolysin-producing strains of Anabaena. We detected previously unidentified strains producing known anabaenolysins A and B and discovered the production of new variants of anabaenolysins C and D. Bioassays demonstrated that anabaenolysins have weak antifungal activity against Candida albicans. Surprisingly, addition of the hydrophilic fraction of the whole-cell extracts increased the antifungal activity of the hydrophobic anabaenolysins. The fraction contained compounds identified by NMR as α-, β-, and γ-cyclodextrins, which undergo acetylation. Cyclodextrins have been used for decades to improve the solubility and bioavailability of many drugs including antifungal compounds. This study shows a natural example of cyclodextrins improving the solubility and efficacy of an antifungal compound in an ancient lineage of photosynthetic bacteria.

Indexed as

Antifungal AgentsBacterial ProteinsCyanobacteriaCyclodextrinsGenes, BacterialMolecular Sequence DataAntifungal AgentsBacterial ProteinsCyclodextrinsbioactive compoundshydroxyamino fatty acidnatural productsNRPSPKS

Identifiers

PMID26474830
PMCPMC4640768
OpenAlexW2208709848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.